Economic growth begins with ideas, innovation and creativity. Since the signing of the Constitution, the U.S. has protected the fruits of creativity and innovation through intellectual property protection, primarily expressed as patents, trademarks, copyright and trade secrets.
As our economy has become even more dependent on innovation, intellectual property issues have been pushed to the forefront. The clashes have led some to question the value and even the legitimacy of IP protection. While some of these attacks come from the libertarian perspective, most originate from the same naïve socialist impulses that so demonstrably failed in the realm of real property—but somehow are seen as thoughtful with respect to IP.
IPI believes that creators have the right to own and control the fruits of their creativity, and that the IP system has done an admirable job of not only incentivizing innovation, but also making creative products and services available to the public and transferring technology to the developing world.
Fake Covid-19 Vaccines Demonstrate (Yet Again) the Threat of Importing Drugs
It would be both ironic and very sad if a person trying to avoid death from Covid-19 died because he took a fake or compromised Covid-19 vaccine.
Florida's Prescription Drug Importation Flop
Florida Gov. DeSantis tries to set up a prescription drug importation program, but no businesses have been willing to take on the risky project—even for $30 million.
Coalition Letter Regarding Patent Trial and Appeal Board (PTAB),
The importance of promoting and protecting America’s patent system is clear -– and so too is the need for Congress to defend the many strides the Trump administration has taken to restore balance in the patent system.
A Massive Threat to Innovation Dodged--for Now
Litigation abuse far predates COVID-19, but its consequences have been magnified as companies scramble to protect themselves against unprecedented threats.
With New Drug Pricing Order, Trump Flirts with Socialized Medicine
The majority of new drugs invented globally are invented in America, in large part because our government does not dictate prices. The president should keep it that way, and, just as he did with NATO, demand that our allies fall in line.
Covid-19 Proves Patents and Competition Are Compatible
The race to create a Covid-19 vaccine and treatment is proving that drug company patents do not stifle competition—they only stifle copying.
IPI Opposes IPI: Problems with a Prescription Drug Pricing Index
IPI urges the Trump administration to forbear importing the price controls of socialist health care systems to the U.S.
Why All the Handwringing Over a COVID-19 Vaccine's Effectiveness?
Before we demand that a COVID-19 vaccine "prevents" contracting the disease in all cases, consider the flu vaccine.
Attempts to Degrade Drug Patents are Counterproductive in This Pandemic
Compulsory licensing deters innovators from investing in drug discovery. It won’t reduce what patients pay.
Coalition Letter Regarding Intellectual Property of COVID-19 Research
Coalition letter in opposition to lawmakers actions that would deny patents, exclusivity, and property rights to biomedical innovators working on vaccines, diagnostics, therapies, and cures for COVID-19.
Total Records: 207
